26.80
전일 마감가:
$28.16
열려 있는:
$27.72
하루 거래량:
2.84M
Relative Volume:
0.73
시가총액:
$3.01B
수익:
-
순이익/손실:
$-99.15M
주가수익비율:
-28.82
EPS:
-0.93
순현금흐름:
$-74.25M
1주 성능:
-0.67%
1개월 성능:
-4.08%
6개월 성능:
-49.38%
1년 성능:
-56.62%
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
VKTX
Viking Therapeutics Inc
|
26.80 | 3.03B | 0 | -99.15M | -74.25M | -0.93 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
2025-04-08 | 개시 | Goldman | Neutral |
2025-02-13 | 개시 | Scotiabank | Sector Outperform |
2025-02-07 | 개시 | Citigroup | Neutral |
2024-12-02 | 개시 | Piper Sandler | Overweight |
2024-11-22 | 개시 | B. Riley Securities | Buy |
2024-11-04 | 재확인 | H.C. Wainwright | Buy |
2024-09-11 | 개시 | JP Morgan | Overweight |
2024-06-27 | 개시 | Morgan Stanley | Overweight |
2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2024-03-26 | 재확인 | Oppenheimer | Outperform |
2024-03-07 | 개시 | Jefferies | Buy |
2024-02-28 | 재확인 | Oppenheimer | Outperform |
2023-05-31 | 재개 | ROTH MKM | Buy |
2023-03-28 | 재확인 | Maxim Group | Buy |
2023-03-17 | 개시 | Stifel | Buy |
2021-07-29 | 재개 | BTIG Research | Buy |
2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2020-06-05 | 개시 | BMO Capital Markets | Outperform |
2020-05-05 | 개시 | Chardan Capital Markets | Buy |
2020-05-01 | 개시 | BTIG Research | Buy |
2019-07-16 | 개시 | Oppenheimer | Outperform |
2019-06-25 | 개시 | Stifel | Buy |
2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2019-03-14 | 재확인 | Maxim Group | Buy |
2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
2018-12-12 | 개시 | B. Riley FBR | Buy |
2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2018-09-18 | 재확인 | H.C. Wainwright | Buy |
2018-09-18 | 재확인 | Maxim Group | Buy |
2018-09-18 | 재확인 | Raymond James | Outperform |
2018-07-20 | 개시 | SunTrust | Buy |
2018-06-28 | 개시 | Raymond James | Outperform |
2018-06-01 | 재확인 | Laidlaw | Buy |
2018-05-31 | 재확인 | Maxim Group | Buy |
2018-03-26 | 재개 | H.C. Wainwright | Buy |
2017-11-28 | 재확인 | Maxim Group | Buy |
2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside? - MSN
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - Yahoo Finance
SA analyst upgrades: NVDA, DJT, VKTX, BRK.A, BEAM (NVDA:NASDAQ) - Seeking Alpha
Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade) - Seeking Alpha
Viking Therapeutics to Participate at Upcoming Investor Conferen - GuruFocus
Viking Therapeutics to Participate at Upcoming Investor Conferences | VKTX Stock News - GuruFocus
Viking Therapeutics Lines Up Presentations at Goldman Sachs, William Blair Healthcare Conferences - Stock Titan
Viking Therapeutics Holds Annual Stockholders Meeting - TipRanks
Viking Therapeutics: Buy It For The Future And Ignore The Noise (NASDAQ:VKTX) - Seeking Alpha
(VKTX) On The My Stocks Page - news.stocktradersdaily.com
Better Weight Loss Stock: Amgen or Viking Therapeutics? - MSN
Viking Therapeutics: Weight-Loss Story Remains Intact (NASDAQ:VKTX) - Seeking Alpha
Bank of America Corp DE Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? - AOL.com
Viking Therapeutics: A High Potential Biotech Play With Manageable Risks (NASDAQ:VKTX) - Seeking Alpha
Viking Therapeutics: Near-Term Catalysts And Competitor Readouts - Seeking Alpha
BNP Paribas Financial Markets Has $1.88 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Viking Therapeutics (VKTX) Stock Rises Amid Novo Nordisk CEO Cha - GuruFocus
Why Viking Therapeutics Stock Bumped 3% Higher Today - Mitrade
When (VKTX) Moves Investors should Listen - news.stocktradersdaily.com
Viking Therapeutics Stock May Struggle After As-Expected Report - MSN
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years - The Motley Fool
Dimensional Fund Advisors LP Has $4.06 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of “Buy” by Analysts - Defense World
Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips - The Globe and Mail
3 Monster Stocks in the Making - Yahoo Finance
Hsbc Holdings PLC Sells 9,437 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Why Viking Therapeutics (VKTX) Stock is Gaining Today - GuruFocus
Why Viking Therapeutics Stock Surged Nearly 20% Higher in April - Yahoo
Viking Therapeutics (VKTX) Sees Unusual Options Activity | VKTX Stock News - GuruFocus
Why Viking Therapeutics Stock Surged Nearly 20% Higher In April - Barchart.com
Why Viking Therapeutics Stock Was Victorious This Week - MSN
(VKTX) Investment Report - news.stocktradersdaily.com
Viking Therapeutics (VKTX) Sees 20% Stock Surge Despite Financial Losses - GuruFocus
Why Viking Therapeutics (VKTX) Stock is Rising Today - GuruFocus
Viking Therapeutics call volume above normal and directionally bullish - TipRanks
Viking Therapeutics (VKTX) Sees Surge in Call Options Trading | VKTX Stock News - GuruFocus
Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 - simplywall.st
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday - The Globe and Mail
This Soaring Stock Just Delivered More Good News. Time to Buy? - AOL.com
Where Will Viking Therapeutics Be in 3 Years? - Yahoo Finance
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):